Ola Landgren

MYD88 and beyond: novel opportunities for diagnosis, prognosis and treatment in Waldenström’s Macroglobulinemia

O. Landgren, N. Tageja, Ola Landgren, 2014, Leukemia.

Improved long-term survival in multiple myeloma up to the age of 80 years

W. Anderson, S. Kristinsson, O. Landgren, 2014, Leukemia.

Polymorphism of the erythropoietin gene promotor and the development of myelodysplastic syndromes subsequent to multiple myeloma

R. Kyle, M. Albitar, O. Landgren, 2012, Leukemia.

Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significance

T Hielscher, H. Goldschmidt, S. Delorme, 2014, Leukemia.

Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS

J. Cerhan, T. Therneau, L. Melton, 2013, Leukemia.

MYD88 L265P somatic mutation in IgM MGUS.

L. Staudt, Ola Landgren, 2012 .